January 2025 Stock Losers on News, Micro Caps Included
Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.
Data as of the trading session of , 18 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
Whole board, unfiltered
100
Ranked drops
-81.42%
Largest, NMRA
99.0%
Below baseline, day +5
14.4%
Median deeper below baseline, day +5
Filter and sort
100 ranked drops in January 2025
Skip the ranked rows and go to the month summaryEvery percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.
| Rank | Symbol | close to close | Session | Catalyst | Announcement | from the pre-news close |
|---|---|---|---|---|---|---|
| 1 | NMRA | -81.42% |
against the close of 2024-12-31
session reconstructed
Session detail |
Other Announcement |
Neumora Therapeutics Reports Data from KOASTAL-1 Study of Navacaprant in Major Depressive Disorder
07:00 ET premarket |
2.8% of the drop was recovered five sessions later. Month end -81.79% on 2025-01-31 |
| 2 | ALLK | -80.47% |
against the close of 2025-01-24
session reconstructed
Session detail |
Clinical Trial Results |
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
07:00 ET premarket |
0.9% of the drop was recovered five sessions later. Month end -80.15% on 2025-01-31 This month ended before the fifth session after the move. |
| 3 | CRGX | -74.30% |
against the close of 2025-01-29
session reconstructed
Session detail |
Clinical Trial Results (terminated) |
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
16:05 ET after hours |
3.2% of the drop was recovered five sessions later. Month end -72.71% on 2025-01-31 This month ended before the fifth session after the move. |
| 4 | GOEV under $25M today | -72.59% |
against the close of 2025-01-17
session reconstructed
Session detail |
Other Announcement |
Canoo Inc. Announces Chapter 7 Bankruptcy Filing
20:15 ET after hours |
0.0% of the drop was recovered five sessions later. Month-end is not shown: no closing price is available for 2025-01-31. |
| 5 | LPTX release reads positive | -71.11% |
against the close of 2025-01-27
session reconstructed
Session detail |
Clinical Trial Results Release reads positive, stock fell 71.11% |
Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
07:00 ET premarket |
Five sessions later the drop was 7.0% bigger, at -76.10%. Month end -75.11% on 2025-01-31 This month ended before the fifth session after the move. |
| 6 | STSS release reads positive | -68.05% |
against the close of 2025-01-27
session reconstructed
Session detail |
Offering / Dilution Release reads positive, stock fell 68.05% |
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
09:00 ET premarket |
Five sessions later the drop was 15.5% bigger, at -78.57%. Month end -73.22% on 2025-01-31 This month ended before the fifth session after the move. |
| 7 | IGMS | -66.29% |
against the close of 2025-01-08
session reconstructed
Session detail |
Other Announcement |
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
13:00 ET intraday |
Five sessions later the drop was 7.8% bigger, at -71.45%. Month end -75.65% on 2025-01-31 |
| 8 | DATS under $25M today | -64.05% |
against the close of 2025-01-07
session reconstructed
Session detail |
Offering / Dilution |
DatChat, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
08:42 ET premarket |
46.2% of the drop was recovered five sessions later. Month end -64.73% on 2025-01-31 |
| 9 | AEON under $25M today | -63.09% |
against the close of 2025-01-03
session reconstructed
Session detail |
Offering / Dilution |
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering
20:02 ET after hours |
Five sessions later the drop was 23.1% bigger, at -77.68%. Month end -77.38% on 2025-01-31 |
| 10 | EHGO under $25M today release reads positive | -61.77% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 61.77% |
EHGO and Zhenjiang High-tech Zone to Jointly Build an AI Data Center and Supply Chain Center for Office Solutions
08:00 ET premarket |
Five sessions later the drop was 12.4% bigger, at -69.42%. Month end -66.36% on 2025-01-31 |
| 11 | JSPR under $25M today | -60.53% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
07:00 ET premarket |
Five sessions later the drop was 15.4% bigger, at -69.85%. Month end -65.78% on 2025-01-31 |
| 12 | LUNA | -56.63% |
against the close of 2025-01-03
session reconstructed
Session detail |
Other Announcement |
Luna Innovations Stock to Be Suspended from Nasdaq Listing
08:30 ET premarket |
9.6% of the drop was recovered five sessions later. Month end -60.98% on 2025-01-31 |
| 13 | XTIA More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -55.74% |
against the close of 2025-01-07
session reconstructed
Session detail |
Offering / Dilution |
XTI Aerospace, Inc. Announces Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
16:00 ET after hours |
Five sessions later the drop was 39.2% bigger, at -77.60%. Month end -82.23% on 2025-01-31 |
| 14 | SABS | -52.52% |
against the close of 2025-01-27
session reconstructed
Session detail |
Clinical Trial Results |
SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142
07:00 ET premarket |
7.0% of the drop was recovered five sessions later. Month end -49.77% on 2025-01-31 This month ended before the fifth session after the move. |
| 15 | VERU | -47.51% |
against the close of 2025-01-24
session reconstructed
Session detail |
Clinical Trial Results |
Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction
06:30 ET premarket |
Five sessions later the drop was 6.8% bigger, at -50.74%. Month end -54.07% on 2025-01-31 This month ended before the fifth session after the move. |
| 16 | MODV under $25M today release reads positive | -47.48% |
against the close of 2025-01-08
session reconstructed
Session detail |
Offering / Dilution Release reads positive, stock fell 47.48% |
Modivcare Raises $105 Million in Incremental Financing Backed by Stakeholders Across the Capital Structure and Takes Strategic Steps to Position Business for the Future
06:00 ET premarket |
Five sessions later the drop was 1.2% bigger, at -48.04%. Month end -67.97% on 2025-01-31 |
| 17 | LODE | -46.77% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement |
Comstock Releases Shareholder Letter
06:30 ET premarket |
20.5% of the drop was recovered five sessions later. Month end -28.11% on 2025-01-31 |
| 18 | ENVB under $25M today | -46.41% |
against the close of 2025-01-30
session reconstructed
Session detail |
Offering / Dilution |
Enveric Biosciences Announces Pricing of $5 Million Public Offering
20:14 ET after hours |
Five sessions later the drop was 23.8% bigger, at -57.44%. Month end -46.41% on 2025-01-31 same session This month ended before the fifth session after the move. |
| 19 | PHIO under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -45.76% |
against the close of 2025-01-13
session reconstructed
Session detail |
Offering / Dilution |
Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
07:00 ET premarket |
Five sessions later the drop was 42.7% bigger, at -65.30%. Month end -68.79% on 2025-01-31 |
| 20 | MRSN | -44.62% |
against the close of 2025-01-08
session reconstructed
Session detail |
Clinical Trial Results |
Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer
06:00 ET premarket |
Five sessions later the drop was 17.5% bigger, at -52.42%. Month end -53.16% on 2025-01-31 |
| 21 | QUBT Also on the opposite board this month on both boards | -43.34% |
against the close of 2025-01-07
session reconstructed
Session detail |
Offering / Dilution |
Quantum Computing, Inc. Announces Private Placement of Common Stock for Proceeds of $100 Million
23:50 ET after hours |
12.8% of the drop was recovered five sessions later. Month end -40.65% on 2025-01-31 |
| 22 | CMTL release reads positive | -43.34% |
against the close of 2025-01-10
session reconstructed
Session detail |
Earnings catalyst from a later release the same session Release reads positive, stock fell 43.34% |
Comtech Announces CEO Transition and Comprehensive Transformation Initiatives
07:00 ET premarket |
5.6% of the drop was recovered five sessions later. Month end -51.57% on 2025-01-31 |
| 23 | EVTL Also on the opposite board this month on both boards | -42.35% |
against the close of 2025-01-22
session reconstructed
Session detail |
Offering / Dilution |
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
16:16 ET after hours |
Five sessions later the drop was 10.2% bigger, at -46.66%. Month end -45.26% on 2025-01-31 |
| 24 | XTIA More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -42.10% |
against the close of 2025-01-08
session reconstructed
Session detail |
Offering / Dilution |
XTI Aerospace Announces Closing of $20 Million Common Stock Offering
14:05 ET intraday |
Five sessions later the drop was 25.0% bigger, at -52.63%. Month end -59.84% on 2025-01-31 |
| 25 | LAES More than one ranked move this month Also on the opposite board this month release reads positive 2+ ranked moves on both boards | -41.54% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 41.54% |
SEALSQ in Cooperation with WISeKey Expands Post-Quantum Footprint in Saudi Arabia
08:20 ET premarket |
70.2% of the drop was recovered five sessions later. Month end -44.50% on 2025-01-31 |
| 26 | BLRX under $25M today | -40.87% |
against the close of 2025-01-03
session reconstructed
Session detail |
Offering / Dilution |
BioLineRx Announces $10 Million Registered Direct Offering
08:57 ET premarket |
Five sessions later the drop was 34.8% bigger, at -55.08%. Month end -67.49% on 2025-01-31 |
| 27 | ATRA release reads positive | -40.50% |
against the close of 2025-01-15
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 40.50% |
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
08:30 ET premarket |
7.3% of the drop was recovered five sessions later. Month end -32.52% on 2025-01-31 |
| 28 | SVMH under $25M today release reads positive | -38.91% |
against the close of 2025-01-14
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 38.91% |
SVM Day 2025: SVM Day Summary – Celebrating Innovation and Growth
15:00 ET intraday |
Month-end is not shown: no closing price is available for 2025-01-31. |
| 29 | SGLY under $25M today | -38.26% |
against the close of 2025-01-23
session reconstructed
Session detail |
Offering / Dilution |
Singularity Announces Pricing of $1.1 Million Registered Direct Offering
12:08 ET intraday |
Five sessions later the drop was 93.1% bigger, at -73.88%. Month end -73.88% on 2025-01-31 |
| 30 | IRWD | -38.17% |
against the close of 2025-01-29
session reconstructed
Session detail |
FDA & Regulatory |
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future
16:05 ET after hours |
Five sessions later the drop was 25.4% bigger, at -47.85%. Month end -37.10% on 2025-01-31 This month ended before the fifth session after the move. |
| 31 | SLRN | -36.96% |
against the close of 2025-01-06
session reconstructed
Session detail |
Clinical Trial Results |
ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
16:00 ET after hours |
Five sessions later the drop was 14.0% bigger, at -42.12%. Month end -43.55% on 2025-01-31 |
| 32 | RCEL release reads positive | -36.42% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 36.42% |
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
16:35 ET after hours |
Five sessions later the drop was 7.8% bigger, at -39.26%. Month end -35.28% on 2025-01-31 |
| 33 | SDST under $25M today | -36.27% |
against the close of 2025-01-22
session reconstructed
Session detail |
Other Announcement |
Stardust Power Breaks Ground on One of The Largest U.S. Battery-Grade Lithium Refineries
07:30 ET premarket |
Five sessions later the drop was 18.6% bigger, at -43.01%. Month end -48.19% on 2025-01-31 |
| 34 | SMX under $25M today | -35.20% |
against the close of 2025-01-10
session reconstructed
Session detail |
Uplisting / Compliance |
SMX Announces Receipt of Nasdaq Listing Deficiency Notice
17:00 ET after hours |
Five sessions later the drop was 71.5% bigger, at -60.38%. Month-end is not shown: no closing price is available for 2025-01-31. |
| 35 | LICN under $25M today | -34.06% |
against the close of 2025-01-27
session reconstructed
Session detail |
Offering / Dilution |
Lichen China Limited Announces $3.4 Million Registered Direct Offering
12:59 ET intraday |
Five sessions later the drop was 38.3% bigger, at -47.10%. Month end -41.01% on 2025-01-31 This month ended before the fifth session after the move. |
| 36 | MBOT Also on the opposite board this month on both boards | -33.92% |
against the close of 2025-01-07
session reconstructed
Session detail |
Offering / Dilution |
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
16:15 ET after hours |
Five sessions later the drop was 9.4% bigger, at -37.10%. Month end -34.98% on 2025-01-31 |
| 37 | BZAI More than one ranked move this month release reads positive 2+ ranked moves | -32.29% |
against the close of 2025-01-15
session reconstructed
Session detail |
Contract / Partnership Release reads positive, stock fell 32.29% |
Blaize Partners With alwaysAI to Revolutionize Real-Time Insights With AI Edge Computing and Advanced Computer Vision Applications
09:06 ET premarket |
1.0% of the drop was recovered five sessions later. Month end -37.50% on 2025-01-31 |
| 38 | TMMI | -32.03% |
against the close of 2025-01-24
session reconstructed
Session detail |
Other Announcement |
TOTAL MULTIMEDIA (TMMI) PREPARES TO BECOME A REPORTING COMPANY
15:50 ET intraday |
Five sessions later the drop was 82.2% bigger, at -58.36%. Month end -57.30% on 2025-01-31 This month ended before the fifth session after the move. |
| 39 | DYN | -31.15% |
against the close of 2025-01-08
session reconstructed
Session detail |
Clinical Trial Results |
Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026
06:30 ET premarket |
Five sessions later the drop was 24.2% bigger, at -38.70%. Month end -38.31% on 2025-01-31 |
| 40 | AMST under $25M today | -30.86% |
against the close of 2025-01-06
session reconstructed
Session detail |
Offering / Dilution |
Amesite Announces Proposed Public Offering
16:59 ET after hours |
34.4% of the drop was recovered five sessions later. Month end -10.12% on 2025-01-31 |
| 41 | SVRE under $25M today | -30.61% |
against the close of 2025-01-29
session reconstructed
Session detail |
Offering / Dilution catalyst from a later release the same session |
SaverOne to Deploy Driver Safety Systems Across Oz Group’s Fleet
09:00 ET premarket |
Five sessions later the drop was 58.6% bigger, at -48.56%. Month end -34.51% on 2025-01-31 This month ended before the fifth session after the move. |
| 42 | UCAR under $25M today More than one ranked move this month 2+ ranked moves | -30.43% |
against the close of 2025-01-23
session reconstructed
Session detail |
Offering / Dilution |
U Power Announces Pricing of $5.0 Million Registered Direct Offering
09:18 ET premarket |
Five sessions later the drop was 118.8% bigger, at -66.58%. Month end -66.58% on 2025-01-31 |
| 43 | QMCO | -30.33% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
Quantum Provides Clarification Regarding Recent Shareholder Transactions
15:01 ET intraday |
52.2% of the drop was recovered five sessions later. Month end -50.34% on 2025-01-31 |
| 44 | QNRX under $25M today | -30.22% |
against the close of 2025-01-22
session reconstructed
Session detail |
Other Announcement |
Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
08:30 ET premarket |
Five sessions later the drop was 68.8% bigger, at -51.00%. Month end -43.52% on 2025-01-31 |
| 45 | MGLD | -29.94% |
against the close of 2025-01-24
session reconstructed
Session detail |
Offering / Dilution |
The Marygold Companies, Inc. Announces Pricing of $2.25 Million Public Offering
19:30 ET after hours |
Five sessions later the drop was 6.4% bigger, at -31.85%. Month end -34.39% on 2025-01-31 This month ended before the fifth session after the move. |
| 46 | XLO | -29.91% |
against the close of 2025-01-21
session reconstructed
Session detail |
Clinical Trial Results |
Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer
17:05 ET after hours |
Five sessions later the drop was 46.0% bigger, at -43.66%. Month end -44.49% on 2025-01-31 |
| 47 | LSTA under $25M today release reads positive | -29.49% |
against the close of 2025-01-21
session reconstructed
Session detail |
Clinical Trial Results Release reads positive, stock fell 29.49% |
Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
08:00 ET premarket |
Five sessions later the drop was 21.7% bigger, at -35.90%. Month end -35.88% on 2025-01-31 |
| 48 | INZY | -28.75% |
against the close of 2025-01-08
session reconstructed
Session detail |
Clinical Trial Results |
Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates
08:00 ET premarket |
Five sessions later the drop was 78.9% bigger, at -51.43%. Month end -48.57% on 2025-01-31 |
| 49 | BPT under $25M today | -28.72% |
against the close of 2025-01-06
session reconstructed
Session detail |
Other Announcement (terminated) |
BP Prudhoe Bay Royalty Trust Announces No Unit Payment for the Fourth Quarter of 2024, Termination of the Trust on December 31, 2024, Commencement of Winding-Up of the Trust, and Receipt of Notice From NYSE Regarding Non-Compliance With Continued...
16:37 ET after hours |
Five sessions later the drop was 16.4% bigger, at -33.42%. Month end -32.19% on 2025-01-31 |
| 50 | GIFT | -28.28% |
against the close of 2025-01-14
session reconstructed
Session detail |
Offering / Dilution |
Giftify, Inc. Announces Pricing of $600,000 Public Offering of Common Stock with No Warrants
09:30 ET intraday |
Five sessions later the drop was 11.0% bigger, at -31.38%. Month end -37.93% on 2025-01-31 |
| 51 | LICY | -27.63% |
against the close of 2025-01-14
session reconstructed
Session detail |
Offering / Dilution |
Li-Cycle Announces Launch of Proposed Underwritten Public Offering
20:02 ET after hours |
Five sessions later the drop was 14.3% bigger, at -31.58%. Month end -33.55% on 2025-01-31 |
| 52 | LITM | -27.34% |
against the close of 2025-01-23
session reconstructed
Session detail |
Offering / Dilution |
Snow Lake Energy Announces Pricing of US$16 Million Offering
22:20 ET after hours |
Five sessions later the drop was 67.9% bigger, at -45.90%. Month end -45.90% on 2025-01-31 |
| 53 | UCAR under $25M today More than one ranked move this month 2+ ranked moves | -27.32% |
against the close of 2025-01-24
session reconstructed
Session detail |
Offering / Dilution catalyst from a later release the same session |
U Power Accelerates EV Adoption in Portugal with Customized UOTTA Battery-swapping Stations
06:00 ET premarket |
Five sessions later the drop was 104.6% bigger, at -55.89%. Month end -51.96% on 2025-01-31 This month ended before the fifth session after the move. |
| 54 | LFWD under $25M today | -27.30% |
against the close of 2025-01-06
session reconstructed
Session detail |
Offering / Dilution |
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
08:05 ET premarket |
Five sessions later the drop was 73.5% bigger, at -47.37%. Month end -54.28% on 2025-01-31 |
| 55 | EVAX More than one ranked move this month release reads positive 2+ ranked moves | -27.17% |
against the close of 2025-01-27
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 27.17% |
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
08:15 ET premarket |
Five sessions later the drop was 67.5% bigger, at -45.50%. Month end -59.08% on 2025-01-31 This month ended before the fifth session after the move. |
| 56 | EVAX More than one ranked move this month 2+ ranked moves | -27.14% |
against the close of 2025-01-29
session reconstructed
Session detail |
Offering / Dilution |
Evaxion announces pricing of $10.8 million public offering
08:00 ET premarket |
30.4% of the drop was recovered five sessions later. Month end -27.58% on 2025-01-31 This month ended before the fifth session after the move. |
| 57 | AEHR | -27.08% |
against the close of 2025-01-13
session reconstructed
Session detail |
Earnings |
Aehr Test Systems Reports Fiscal 2025 Second Quarter Financial Results and Reiterates Full Year Financial Guidance
16:05 ET after hours |
21.5% of the drop was recovered five sessions later. Month end -29.14% on 2025-01-31 |
| 58 | QSI More than one ranked move this month release reads positive 2+ ranked moves | -27.03% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 27.03% |
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
08:00 ET premarket |
71.3% of the drop was recovered five sessions later. Month end -25.14% on 2025-01-31 |
| 59 | BZAI More than one ranked move this month 2+ ranked moves | -26.66% |
against the close of 2025-01-14
session reconstructed
Session detail |
Leadership Change |
Blaize Holdings, Inc. Appoints Lane Bess as Chairman of Its Board of Directors
08:30 ET premarket |
Five sessions later the drop was 82.5% bigger, at -48.66%. Month end -54.16% on 2025-01-31 |
| 60 | WLDS under $25M today Also on the opposite board this month release reads positive on both boards | -26.60% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement Release reads positive, stock fell 26.60% |
Wearable Devices and RayNeo to Unveil Transformative Gesture-Controlled AR Glasses Powered by Mudra Neural Wristband and Snapdragon XR Platform at CES®
08:45 ET premarket |
Five sessions later the drop was 14.8% bigger, at -30.54%. Month end -44.33% on 2025-01-31 |
| 61 | UBX under $25M today Also on the opposite board this month on both boards | -26.52% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
UNITY Biotechnology Reports Granting of New Employment Inducement Award
16:10 ET after hours |
75.0% of the drop was recovered five sessions later. Month end +22.65% on 2025-01-31 |
| 62 | ESTA | -26.38% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement |
Establishment Labs Announces CEO Transition
08:00 ET premarket |
15.3% of the drop was recovered five sessions later. Month end -30.01% on 2025-01-31 |
| 63 | OCEA under $25M today | -26.33% |
against the close of 2025-01-28
session reconstructed
Session detail |
Other Announcement |
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
08:30 ET premarket |
Five sessions later the drop was 111.9% bigger, at -55.79%. Month end -40.58% on 2025-01-31 This month ended before the fifth session after the move. |
| 64 | LAES More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -26.22% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
SEALSQ Secure Chips and Development Boards now Available on DigiKey Marketplace
08:30 ET premarket |
Five sessions later the drop was 49.4% bigger, at -39.16%. Month end -55.52% on 2025-01-31 |
| 65 | JXG release reads positive | -26.21% |
against the close of 2025-01-14
session reconstructed
Session detail |
Contract / Partnership Release reads positive, stock fell 26.21% |
JX Luxventure Signs Blockbuster USD20,000,0000 Strategic Annual Cooperation Agreement
09:39 ET intraday |
Five sessions later the drop was 16.9% bigger, at -30.65%. Month end -23.66% on 2025-01-31 |
| 66 | RVSN under $25M today | -26.21% |
against the close of 2025-01-14
session reconstructed
Session detail |
Uplisting / Compliance |
Rail Vision Regains Compliance with Nasdaq Minimum Bid Price Rule
09:35 ET intraday |
Five sessions later the drop was 55.4% bigger, at -40.72%. Month end -50.45% on 2025-01-31 |
| 67 | AVDL | -26.10% |
against the close of 2025-01-08
session reconstructed
Session detail |
Earnings |
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
16:15 ET after hours |
Five sessions later the drop was 5.4% bigger, at -27.50%. Month end -26.10% on 2025-01-31 |
| 68 | ACXP under $25M today release reads positive | -26.01% |
against the close of 2025-01-06
session reconstructed
Session detail |
Offering / Dilution Release reads positive, stock fell 26.01% |
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
17:35 ET after hours |
Five sessions later the drop was 30.5% bigger, at -33.95%. Month end -32.97% on 2025-01-31 |
| 69 | JBLU | -25.71% |
against the close of 2025-01-27
session reconstructed
Session detail |
Earnings |
JetBlue Announces Fourth Quarter 2024 Results
07:00 ET premarket |
8.2% of the drop was recovered five sessions later. Month end -18.67% on 2025-01-31 This month ended before the fifth session after the move. |
| 70 | PHIO under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards | -25.70% |
against the close of 2025-01-14
session reconstructed
Session detail |
Offering / Dilution |
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
07:00 ET premarket |
Five sessions later the drop was 34.8% bigger, at -34.64%. Month end -42.46% on 2025-01-31 |
| 71 | FTAI | -25.44% |
against the close of 2025-01-17
session reconstructed
Session detail |
Other Announcement |
FTAI Aviation Announces Full Redemption of Outstanding 8.00% Fixed-to-Floating Rate Series B Cumulative Perpetual Redeemable Preferred Shares
16:15 ET after hours |
56.8% of the drop was recovered five sessions later. Month end -10.54% on 2025-01-31 |
| 72 | RZLV release reads positive | -25.23% |
against the close of 2025-01-10
session reconstructed
Session detail |
M&A / Acquisition Release reads positive, stock fell 25.23% |
Rezolve Ai Poised for Global Growth as it enters 2025 with Strong Customer Acquisitions, Strategic Partnerships, and Groundbreaking Innovations
08:00 ET premarket |
56.8% of the drop was recovered five sessions later. Month end -22.12% on 2025-01-31 |
| 73 | NEP | -25.13% |
against the close of 2025-01-27
session reconstructed
Session detail |
Earnings catalyst from a later release the same session |
NextEra Energy reaffirms previously announced long-term financial expectations
07:30 ET premarket |
Month end -33.29% on 2025-01-31 |
| 74 | FFIE More than one ranked move this month 2+ ranked moves | -25.00% |
against the close of 2025-01-08
session reconstructed
Session detail |
Other Announcement |
Faraday Future Announces FX’s First Class AI-MPV Product Strategy and Planned Product—FX Super One, Giving FX Business Strategy Updates From Las Vegas
20:00 ET after hours |
Five sessions later the drop was 9.6% bigger, at -27.40%. Month end -36.54% on 2025-01-31 |
| 75 | CSAI under $25M today | -24.71% |
against the close of 2025-01-30
session reconstructed
Session detail |
Contract / Partnership |
Cloudastructure Announces Partnership with Global Leader in Commercial Real Estate Services and Investments Managing Tens of Thousands of Properties Worldwide
09:00 ET premarket |
Five sessions later the drop was 240.1% bigger, at -84.03%. Month end -24.71% on 2025-01-31 same session This month ended before the fifth session after the move. |
| 76 | INTZ under $25M today | -24.52% |
against the close of 2025-01-03
session reconstructed
Session detail |
Offering / Dilution |
Intrusion Inc. Announces $7.5 Million Registered Direct Offering
09:28 ET premarket |
Five sessions later the drop was 99.1% bigger, at -48.81%. Month end -58.81% on 2025-01-31 |
| 77 | MANH | -24.49% |
against the close of 2025-01-28
session reconstructed
Session detail |
Earnings |
Manhattan Associates Reports Record Fourth Quarter and Full Year Results
16:05 ET after hours |
Five sessions later the drop was 30.6% bigger, at -31.98%. Month end -29.32% on 2025-01-31 This month ended before the fifth session after the move. |
| 78 | QSI More than one ranked move this month 2+ ranked moves | -24.46% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
08:00 ET premarket |
Five sessions later the drop was 11.7% bigger, at -27.32%. Month end -43.35% on 2025-01-31 |
| 79 | FFIE More than one ranked move this month 2+ ranked moves | -24.21% |
against the close of 2025-01-03
session reconstructed
Session detail |
Other Announcement |
Faraday Future to Host Exclusive Private Showcase and Experience of FX Prototype Mules in Las Vegas, NV
23:16 ET after hours |
Five sessions later the drop was 131.2% bigger, at -55.97%. Month end -58.49% on 2025-01-31 |
| 80 | EDU | -23.22% |
against the close of 2025-01-17
session reconstructed
Session detail |
Earnings |
New Oriental Announces Results for the Second Fiscal Quarter Ended November 30, 2024
04:18 ET premarket |
5.4% of the drop was recovered five sessions later. Month end -19.86% on 2025-01-31 |
| 81 | RDUS | -22.75% |
against the close of 2025-01-07
session reconstructed
Session detail |
Earnings |
Radius Recycling Reports First Quarter Fiscal 2025 Financial Results
16:30 ET after hours |
20.3% of the drop was recovered five sessions later. Month end -18.69% on 2025-01-31 |
| 82 | VRME under $25M today | -22.52% |
against the close of 2025-01-13
session reconstructed
Session detail |
Offering / Dilution |
VerifyMe Enters into a Warrant Inducement Transaction for $4.7 Million in Proceeds
08:00 ET premarket |
Five sessions later the drop was 86.0% bigger, at -41.89%. Month end -65.13% on 2025-01-31 |
| 83 | HUSA | -22.36% |
against the close of 2025-01-21
session reconstructed
Session detail |
Offering / Dilution |
Houston American Energy Corp. Announces $4,420,000 Registered Direct Offering.
08:30 ET premarket |
Five sessions later the drop was 66.1% bigger, at -37.13%. Month end -37.13% on 2025-01-31 |
| 84 | UCAR under $25M today More than one ranked move this month 2+ ranked moves | -22.33% |
against the close of 2025-01-28
session reconstructed
Session detail |
Contract / Partnership |
U Power and Ezzy Transporter Establish Joint Venture to Bring UOTTA Battery-Swapping Solutions to Thailand
07:00 ET premarket |
Five sessions later the drop was 38.3% bigger, at -30.88%. Month end -36.10% on 2025-01-31 This month ended before the fifth session after the move. |
| 85 | VUZI | -21.86% |
against the close of 2025-01-06
session reconstructed
Session detail |
Other Announcement |
Vuzix to Unveil Cutting-Edge Ultralite ODM/OEM Reference Designs and Advanced Waveguide Solutions at CES 2025
08:30 ET premarket |
Five sessions later the drop was 80.9% bigger, at -39.54%. Month end -21.29% on 2025-01-31 |
| 86 | BDMD Also on the opposite board this month on both boards | -21.81% |
against the close of 2025-01-17
session reconstructed
Session detail |
Other Announcement |
Dr. Emad Kandil Achieves Milestone of 100 Microwave Ablation Cases in Thyroid Care
08:30 ET premarket |
18.7% of the drop was recovered five sessions later. Month end -19.89% on 2025-01-31 |
| 87 | ILLR under $25M today | -21.81% |
against the close of 2025-01-17
session reconstructed
Session detail |
Other Announcement |
TikTok "Refugees" Flock to U.S. Owned Rival, Triller
14:53 ET intraday |
Five sessions later the drop was 9.4% bigger, at -23.87%. Month end -21.81% on 2025-01-31 |
| 88 | CTKB | -21.76% |
against the close of 2025-01-14
session reconstructed
Session detail |
Earnings |
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
08:00 ET premarket |
0.6% of the drop was recovered five sessions later. Month end -29.06% on 2025-01-31 |
| 89 | PEPG | -21.74% |
against the close of 2025-01-29
session reconstructed
Session detail |
Other Announcement |
PepGen Announces CONNECT Program Updates
16:05 ET after hours |
Five sessions later the drop was 15.0% bigger, at -25.00%. Month end -29.89% on 2025-01-31 This month ended before the fifth session after the move. |
| 90 | IRBT under $25M today | -21.72% |
against the close of 2025-01-10
session reconstructed
Session detail |
Earnings |
iRobot Announces Preliminary Fourth-Quarter 2024 Financial Results
07:00 ET premarket |
Five sessions later the drop was 17.2% bigger, at -25.45%. Month end -26.41% on 2025-01-31 |
| 91 | SIG | -21.66% |
against the close of 2025-01-13
session reconstructed
Session detail |
Earnings catalyst from a later release the same session |
Signet Jewelers to Webcast ICR Fireside Chat
16:30 ET after hours |
8.5% of the drop was recovered five sessions later. Month end -20.00% on 2025-01-31 |
| 92 | VISL under $25M today | -21.57% |
against the close of 2025-01-30
session reconstructed
Session detail |
Uplisting / Compliance |
Vislink Announces Delisting from Nasdaq and Potential SEC Deregistration
15:58 ET intraday |
Five sessions later the drop was 38.9% bigger, at -29.97%. Month end -21.57% on 2025-01-31 same session This month ended before the fifth session after the move. |
| 93 | QLGN under $25M today | -21.42% |
against the close of 2025-01-27
session reconstructed
Session detail |
Other Announcement |
Qualigen to participate in next funding round for NanoSynex
08:00 ET premarket |
39.4% of the drop was recovered five sessions later. Month end -17.64% on 2025-01-31 This month ended before the fifth session after the move. |
| 94 | WKEY Also on the opposite board this month on both boards | -21.33% |
against the close of 2025-01-10
session reconstructed
Session detail |
Other Announcement |
WISeKey’s Subsidiary, WISeSat.Space to Launch a New-Generation Satellite on January 14, a Significant Milestone in the Creation of a Global Satellite Constellation
08:25 ET premarket |
94.9% of the drop was recovered five sessions later. Month end -25.50% on 2025-01-31 |
| 95 | ZNTL | -21.25% |
against the close of 2025-01-28
session reconstructed
Session detail |
Clinical Trial Results catalyst from a later release the same session |
Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
16:05 ET after hours |
49.0% of the drop was recovered five sessions later. Month end -27.50% on 2025-01-31 This month ended before the fifth session after the move. |
| 96 | GXAI under $25M today | -21.25% |
against the close of 2025-01-07
session reconstructed
Session detail |
Other Announcement |
Gaxos to Participate in The Sequire Investor Summit on January 21st – 23rd in San Juan, Puerto Rico
07:30 ET premarket |
Five sessions later the drop was 34.4% bigger, at -28.57%. Month end -44.32% on 2025-01-31 |
| 97 | MRVI | -20.88% |
against the close of 2025-01-08
session reconstructed
Session detail |
Other Announcement |
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
16:10 ET after hours |
Five sessions later the drop was 6.3% bigger, at -22.19%. Month end -19.58% on 2025-01-31 |
| 98 | INM under $25M today | -20.79% |
against the close of 2025-01-21
session reconstructed
Session detail |
Other Announcement |
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds
07:30 ET premarket |
Five sessions later the drop was 45.7% bigger, at -30.30%. Month end -39.01% on 2025-01-31 |
| 99 | NEO | -20.63% |
against the close of 2025-01-08
session reconstructed
Session detail |
Other Announcement |
NeoGenomics Announces Chief Executive Officer Succession
07:05 ET premarket |
Five sessions later the drop was 14.6% bigger, at -23.64%. Month end -23.16% on 2025-01-31 |
| 100 | NNE | -20.54% |
against the close of 2025-01-10
session reconstructed
Session detail |
M&A / Acquisition |
NANO Nuclear Energy Closes Acquisition of Patented Micro Modular Reactor (MMR®) and Pylon Transportable Reactor Technologies
08:00 ET premarket |
It recovered the whole drop and closed 25.41% above the pre-news price. Month end +50.51% on 2025-01-31 |
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 216 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band
3 candidate events for this board could not be anchored to a trading session and are not listed.
1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.
Company names are not shown on months older than a year, because only the current holder of each ticker is known.
Whole board, unfiltered
In January 2025, the median decliner was 14.4% deeper below its pre-news close five sessions later; the largest catalyst group was Other Announcement, 37 of the 100 events, at a median of -26.6%.
Close-to-close change on the measured trading session, against the previous close.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
Which catalysts drove the board
Swipe the table sideways for the day +5 columns.
| Catalyst | Events | Share of board | Median move close to close | Median at day +5 | Still below the pre-news close at day +5 |
|---|---|---|---|---|---|
| Other Announcement | 37 | 37.0% | -26.6% | -32.0% of 36 | 100.0% of 36 |
| Offering / Dilution | 29 | 29.0% | -30.9% | -47.1% | 100.0% of 29 |
| Clinical Trial Results | 12 | 12.0% | -40.8% | -49.8% | 100.0% of 12 |
| Earnings | 11 | 11.0% | -24.5% | -22.8% of 10 | 100.0% of 10 |
| Contract / Partnership | 4 | 4.0% | Fewer than 10 events in this group, so no figures are shown. | ||
The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.
4 other catalyst types, 7 events: Uplisting / Compliance, M&A / Acquisition, FDA & Regulatory, Leadership Change.
How much of the drop held
| Horizon | Still below the pre-news close close to close | Median change since the measured close as a share of the drop |
|---|---|---|
| Day +1 | 99.0% of 100 | 4.6% deeper below baseline, of 100 |
| Day +5 | 99.0% of 98 | 14.4% deeper below baseline, of 98 |
| Month end | 97.9% of 94 | 19.0% deeper below baseline, of 94 |
| Month end falls before day +5 for 21 of these 94 events, so this row is not a later horizon than the one above it. 94 of the 100 events have a month-end close later than the measured session; 3 have it on the measured session itself, and 3 have no month-end close. | ||
Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.
Repeat runners
Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.
Moved twice or more inside January 2025
Two or more ranked moves this month, each on a different trading day.
| Symbol | Measured sessions | Largest drop |
|---|---|---|
| UCAR | 3Offering / Dilution, Contract / Partnership | -30.43% |
| XTIA | 2Offering / Dilution | -55.74% |
| PHIO | 2Offering / Dilution | -45.76% |
| LAES | 2Other Announcement | -41.54% |
| BZAI | 2Contract / Partnership, Leadership Change | -32.29% |
| EVAX | 2Other Announcement, Offering / Dilution | -27.17% |
| QSI | 2Other Announcement | -27.03% |
| FFIE | 2Other Announcement | -25.00% |
Also fallen on news in earlier months
Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.
| Symbol | Months | Largest drop |
|---|---|---|
| AILE | 2024-12, 2024-11 | -78.53% |
| SPGC | 2024-12, 2024-10 | -73.36% |
| BCTX | 2024-12, 2024-10 | -39.89% |
| RENB | 2024-12, 2024-10 | -31.71% |
| PBM | 2024-12, 2024-10 | -26.38% |
| AMPG | 2024-12, 2024-11 | -25.00% |
| OPTX | 2024-12, 2024-11 | -31.13% |
| UAVS | 2024-12, 2024-10 | -21.84% |
| AMIX | 2024-11, 2024-10 | -53.55% |
| KXIN | 2024-11, 2024-10 | -40.19% |
| LILM | 2024-11, 2024-10 | -36.97% |
| DBGI | 2024-11, 2024-10 | -33.83% |
What the board was made of
Price before the move
Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.
When the announcement landed
Volume against normal
4 events have too little trading history for a relative volume, and are not in the tiers above.
Industry
31 other industries, 37 events
Industry not known: 23.0%
When the release and the price disagreed
17 events on this board carry the flag.
Flagged events sat 2.2 percentage points above the rest of the board five sessions later.
- Median at day +5, flagged
- -36.7%
- Median at day +5, not flagged
- -38.9%
Against December 2024
100 events in the comparable window.
December 2024 median -32.3%, selected from the 6,649 events in that month's eligible pool
January 2025 median -28.0%, 4.3 points shallower than December 2024. January 2025's median is taken over the 100 ranked rows, selected from the 8,642 events in that month's eligible pool.
The two windows drew on pools of very different size, so part of the gap between the medians is how deep into each pool the top hundred reaches rather than how severe the moves were.
How this ranking is measured
Close-to-close change on the measured trading session, against the previous close.
- An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
- One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
- A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
- No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.
Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.
Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.
Market cap is not shown on months older than a year, because only today's figure exists.
NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.
On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.
This archive starts at 2020-04, the first month with ranked moves.